MedPath

UNIVERSITY COLLEGE LONDON

UNIVERSITY COLLEGE LONDON logo
🇬🇧United Kingdom
Ownership
Private
Established
1826-02-11
Employees
10K
Market Cap
-
Website
http://www.ucl.ac.uk

A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

Phase 2
Active, not recruiting
Conditions
Cutaneous T Cell Lymphoma
Mycosis Fungoides/Sezary Syndrome
Interventions
Radiation: Radiotherapy
First Posted Date
2017-12-28
Last Posted Date
2024-12-09
Lead Sponsor
University College, London
Target Recruit Count
46
Registration Number
NCT03385226
Locations
🇬🇧

Guy's & St Thomas', London, United Kingdom

🇬🇧

The Christie, Manchester, United Kingdom

🇬🇧

University Hospital Birmingham, Birmingham, United Kingdom

and more 8 locations

A Factor IX Gene Therapy Study (FIX-GT)

Phase 1
Terminated
Conditions
Hemophilia B
Interventions
Biological: FLT180a
First Posted Date
2017-12-12
Last Posted Date
2022-12-02
Lead Sponsor
University College, London
Target Recruit Count
10
Registration Number
NCT03369444
Locations
🇬🇧

Basingstoke Haemostasis and Thrombosis Centre, Basingstoke, United Kingdom

🇮🇪

St James's Hospital, Dublin, Ireland

🇺🇸

St Jude Children's Research Hospital, Memphis, Tennessee, United States

and more 8 locations

Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
Interventions
Dietary Supplement: Vivomixx
Dietary Supplement: Placebo
First Posted Date
2017-12-12
Last Posted Date
2022-03-08
Lead Sponsor
University College, London
Target Recruit Count
69
Registration Number
NCT03369431
Locations
🇬🇧

University College Hospital, London, United Kingdom

GECo: Implementation and Effectiveness of COPD Case-Finding in Low and Middle Income Countries

Completed
Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2017-12-07
Last Posted Date
2023-06-18
Lead Sponsor
University College, London
Target Recruit Count
10709
Registration Number
NCT03365713
Locations
🇺🇬

Makerere University Lung Institute, Makerere, Uganda

🇵🇪

Universidad Peruana Cayetano Heredia, Lima, Peru

🇳🇵

Institute of Medicine, Kathmandu, Nepal

ORaClES: A Trial to Improve Prognostication

Not Applicable
Completed
Conditions
Terminal Illness
Interventions
Other: Online training resource
First Posted Date
2017-12-04
Last Posted Date
2020-04-10
Lead Sponsor
University College, London
Target Recruit Count
170
Registration Number
NCT03360812
Locations
🇬🇧

Brighton and Sussex Medical School, Brighton, United Kingdom

🇬🇧

Imperial College London, London, United Kingdom

🇬🇧

St George's Medical School, London, United Kingdom

and more 2 locations

GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Behavioral: COPD Self-Management Plan
First Posted Date
2017-12-02
Last Posted Date
2017-12-04
Lead Sponsor
University College, London
Target Recruit Count
240
Registration Number
NCT03359915
Locations
🇵🇪

Universidad Peruana Cayetano Heredia, Lima, Peru

🇳🇵

Institute of Medicine, Kathmandu, Nepal

🇺🇬

Makerere University Lung Institute, Makerere, Uganda

Photodynamic Therapy for the Prevention of Lung Cancer

Phase 2
Withdrawn
Conditions
Squamous Cell Lung Cancer
Lung Cancer
Interventions
Other: Photodynamic Therapy (PDT)
First Posted Date
2017-11-17
Last Posted Date
2019-02-01
Lead Sponsor
University College, London
Registration Number
NCT03346304

Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response

Phase 4
Completed
Conditions
Obesity
Interventions
First Posted Date
2017-11-14
Last Posted Date
2020-11-05
Lead Sponsor
University College, London
Target Recruit Count
70
Registration Number
NCT03341429
Locations
🇬🇧

UCLH, London, United Kingdom

ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma

Phase 2
Active, not recruiting
Conditions
Hodgkin Lymphoma
Interventions
First Posted Date
2017-11-09
Last Posted Date
2024-05-10
Lead Sponsor
University College, London
Target Recruit Count
78
Registration Number
NCT03337919
Locations
🇬🇧

Royal Cornwall Hospital, Truro, Cornwall, United Kingdom

🇬🇧

St Bartholomew's Hospital, London, United Kingdom

🇬🇧

Leicester Royal Infirmary, Leicester, United Kingdom

and more 7 locations

Experiencing Loss and Planning Ahead Study

Completed
Conditions
Grief
First Posted Date
2017-11-06
Last Posted Date
2020-10-19
Lead Sponsor
University College, London
Target Recruit Count
150
Registration Number
NCT03332979
Locations
🇬🇧

University College London, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath